Three AChE inhibitors (AChEIs), namely, donepezil, galantamine, and rivastigmine, are the representatives of so-called “cholinergic hypothesis” used currently as the main drugs for AD treatment [5]. This evidence concerns the gene ACHE and Alzheimer disease.